The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.
D000818:Animals; D000951:Antigens, Neoplasm; D002471:Cell Transformation, Neoplastic; D003602:Cytotoxicity, Immunologic; D005260:Female; D006649:Histocompatibility Antigens; D007111:Immunity, Cellular; D007942:Leukemia, Experimental / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D010954:Plasmacytoma / Q000276:immunology; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014301:Trinitrobenzenes / Q000276:immunology
D000951:Antigens, Neoplasm; D006649:Histocompatibility Antigens; D014301:Trinitrobenzenes